. . . . . "1041942769"^^ . . . . . . . . "1984"^^ . . . "Cynapsus Therapeutics Inc."@en . . . . . . . . . . "Cynapsus Therapeutics Inc. is a specialty pharmaceutical company developing a drug to treat the motor symptoms of Parkinson's disease. Based in Toronto, Ontario, Canada. Formerly named Cannasat Therapeutics they changed their name to Cynapsus Therapeutics in 2010. In September 2016, Sunovion (a subsidiary of Dainippon Sumitomo Pharma) announced it would acquire Cynapsus Therapeutics for approximately $624 million."@en . . "4064"^^ . . . . . . . . . . . . . . . . . . "Cynapsus Therapeutics"@en . . . . . . . . "Cynapsus Therapeutics Inc."@en . "20421670"^^ . "File:Cynapsus Therapeutics logo.jpg"@en . . . . "Marlborough, Massachusetts, United States"@en . . "Cynapsus Therapeutics Inc. is a specialty pharmaceutical company developing a drug to treat the motor symptoms of Parkinson's disease. Based in Toronto, Ontario, Canada. Formerly named Cannasat Therapeutics they changed their name to Cynapsus Therapeutics in 2010. In September 2016, Sunovion (a subsidiary of Dainippon Sumitomo Pharma) announced it would acquire Cynapsus Therapeutics for approximately $624 million."@en . . . . . . . . "1984"^^ .